Siobhan M. Dolan, MD, MPH - Reproductive Genetics

This topic has not yet been translated. (Tema aún no ha sido traducido.)

Dr. Siobhan M. Dolan reviews content for Healthwise, a nonprofit organization with a mission to help people make better health decisions. She has authored numerous print publications and given lectures at over 70 invited presentations, including the World Health Organization Preterm Birth International Conference in Geneva, Switzerland, and the United States Department of State, Bureau of Educational and Cultural Affairs, International Visitor Program. Dr. Dolan is an Associate Professor of obstetrics and gynecology and women's health in the Division of Reproductive Genetics at Albert Einstein College of Medicine in the Bronx, New York.

Education and Training

MD: Harvard Medical School, Boston, MA, 1993

Internship and Residency in Obstetrics and Gynecology: The New York Hospital, Cornell Medical Center, New York, NY, 1993-1995

Yale University, New Haven Hospital, New Haven, CT:

  • Residency in Obstetrics and Gynecology, 1995-1998
  • Administrative Chief, 1997-1998

MA: Columbia University, Mailman School of Public Health, New York, NY, 2004

Fellowship in Clinical Genetics: Albert Einstein College of Medicine and Montefiore Medical Center, Bronx, NY, 2001-2004


American Board of Medical Genetics

American Board of Obstetrics and Gynecology

Academic Appointments

Albert Einstein College of Medicine and Montefiore Medical Center, Department of Obstetrics and Gynecology and Women's Health, Division of Reproductive Genetics, Bronx, NY:

  • Associate Medical Professor, 2007-present
  • Assistant Professor, 2001-2007

Faculty Instructor in Public Health Genetics, Sarah Lawrence College Human Genetics Program, Bronxville, NY, 2003-present

Clinical Instructor, Yale University School of Medicine, New Haven, CT, 1998-2001

Financial Disclosure

The final approval of Healthwise content is always made by a clinician with no financial conflicts.

Dr. Dolan in a consultant for March of Dimes Birth Defects Foundation and receives grant support from the Gates Foundation. She holds stocks in Omeros and Sequenom.

Current as of: August 23, 2013